CODX vs LLY
Co-Diagnostics, Inc. Common Stock (CODX) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
CODX currently screens at market cap $31.4M. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the CODX and LLY stock pages for the full models.
Not investment advice.